TMS Co., Ltd. (TYO:4891)
122.00
-5.00 (-3.94%)
Jun 3, 2026, 3:30 PM JST
TMS Co., Ltd. Market Cap
TMS Co., Ltd. has a market cap or net worth of 5.78 billion as of June 3, 2026. Its market cap has increased by 9.34% in one year.
Market Cap
5.78B
Enterprise Value
3.14B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
122.00
Market Cap Chart
Since November 22, 2022, TMS Co., Ltd.'s market cap has decreased from 28.10B to 5.78B, a decrease of -79.44%. That is a compound annual growth rate of -36.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 5.78B | -1.55% |
| Dec 30, 2025 | 5.87B | -33.26% |
| Dec 30, 2024 | 8.79B | 27.76% |
| Dec 29, 2023 | 6.88B | -69.65% |
| Dec 30, 2022 | 22.68B | -19.29% |
| Nov 22, 2022 | 28.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BrightPath Biotherapeutics | 7.16B |
| ADR120S | 7.08B |
| StemCell Institute | 6.83B |
| Kubota Pharmaceutical Holdings | 6.46B |
| Soiken Holdings | 6.38B |
| CellSource | 6.33B |
| Noile-Immune Biotech | 5.80B |
| Chiome Bioscience | 5.52B |